Abigail Anne Risic

Array ( [id] => 7629736 [patent_doc_number] => 06818620 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-16 [patent_title] => 'Synthetic compounds and compositions with enhanced cell binding' [patent_app_type] => B2 [patent_app_number] => 09/816737 [patent_app_country] => US [patent_app_date] => 2001-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 9510 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/818/06818620.pdf [firstpage_image] =>[orig_patent_app_number] => 09816737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843589 [patent_doc_number] => 20030148936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Bioactive peptides' [patent_app_type] => new [patent_app_number] => 09/798026 [patent_app_country] => US [patent_app_date] => 2001-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25281 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148936.pdf [firstpage_image] =>[orig_patent_app_number] => 09798026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1189206 [patent_doc_number] => 06734210 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-11 [patent_title] => 'Therapeutically improved salts of azelaic acid' [patent_app_type] => B2 [patent_app_number] => 09/791358 [patent_app_country] => US [patent_app_date] => 2001-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2307 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/734/06734210.pdf [firstpage_image] =>[orig_patent_app_number] => 09791358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 448682 [patent_doc_number] => 07250397 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-31 [patent_title] => 'Antiarrhythmic peptides' [patent_app_type] => utility [patent_app_number] => 09/792286 [patent_app_country] => US [patent_app_date] => 2001-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 0 [patent_no_of_words] => 58705 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/250/07250397.pdf [firstpage_image] =>[orig_patent_app_number] => 09792286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6898789 [patent_doc_number] => 20010046954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-29 [patent_title] => 'Non-aqueous injectable formulations for extended release of somatotropin' [patent_app_type] => new [patent_app_number] => 09/789392 [patent_app_country] => US [patent_app_date] => 2001-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10407 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20010046954.pdf [firstpage_image] =>[orig_patent_app_number] => 09789392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1177901 [patent_doc_number] => 06743770 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-01 [patent_title] => 'Nutritional supplement for the management of stress' [patent_app_type] => B2 [patent_app_number] => 09/783709 [patent_app_country] => US [patent_app_date] => 2001-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5232 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/743/06743770.pdf [firstpage_image] =>[orig_patent_app_number] => 09783709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1110662 [patent_doc_number] => 06806063 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-10-19 [patent_title] => 'Factor VII or VIIa-like molecules' [patent_app_type] => B2 [patent_app_number] => 09/782587 [patent_app_country] => US [patent_app_date] => 2001-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30004 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/806/06806063.pdf [firstpage_image] =>[orig_patent_app_number] => 09782587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 868357 [patent_doc_number] => 07365053 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-29 [patent_title] => 'Selective N-acylation of A82846 glygopeptides analogs' [patent_app_type] => utility [patent_app_number] => 10/203533 [patent_app_country] => US [patent_app_date] => 2001-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13601 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/365/07365053.pdf [firstpage_image] =>[orig_patent_app_number] => 10203533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6987223 [patent_doc_number] => 20010036916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-01 [patent_title] => 'Insoluble insulin compositions' [patent_app_type] => new [patent_app_number] => 09/761903 [patent_app_country] => US [patent_app_date] => 2001-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 31153 [patent_no_of_claims] => 135 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20010036916.pdf [firstpage_image] =>[orig_patent_app_number] => 09761903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674809 [patent_doc_number] => 20030060412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Process for solubilizing glucagon-like peptide 1compounds' [patent_app_type] => new [patent_app_number] => 10/169657 [patent_app_country] => US [patent_app_date] => 2002-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7368 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060412.pdf [firstpage_image] =>[orig_patent_app_number] => 10169657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6908305 [patent_doc_number] => 20010011072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-02 [patent_title] => 'Method of inhibiting fibrosis with a somatostatin agonist' [patent_app_type] => new [patent_app_number] => 09/761605 [patent_app_country] => US [patent_app_date] => 2001-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8665 [patent_no_of_claims] => 141 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20010011072.pdf [firstpage_image] =>[orig_patent_app_number] => 09761605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6679069 [patent_doc_number] => 20030229210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Process for the preparation of active somatotropin from inclusion bodies' [patent_app_type] => new [patent_app_number] => 09/811789 [patent_app_country] => US [patent_app_date] => 2001-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4656 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20030229210.pdf [firstpage_image] =>[orig_patent_app_number] => 09811789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6438916 [patent_doc_number] => 20020128205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Inhibiting GS-FDH to modulate NO bioactivity' [patent_app_type] => new [patent_app_number] => 09/757610 [patent_app_country] => US [patent_app_date] => 2001-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9586 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128205.pdf [firstpage_image] =>[orig_patent_app_number] => 09757610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6961807 [patent_doc_number] => 20010012829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-09 [patent_title] => 'Transepithelial delivery GLP-1 derivatives' [patent_app_type] => new [patent_app_number] => 09/757788 [patent_app_country] => US [patent_app_date] => 2001-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12196 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20010012829.pdf [firstpage_image] =>[orig_patent_app_number] => 09757788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1147459 [patent_doc_number] => 06770306 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-03 [patent_title] => 'Drugs for reducing vaginal acidity and treatment of vaginitis, and the use thereof' [patent_app_type] => B1 [patent_app_number] => 09/674062 [patent_app_country] => US [patent_app_date] => 2001-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6804 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/770/06770306.pdf [firstpage_image] =>[orig_patent_app_number] => 09674062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6476617 [patent_doc_number] => 20020022588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-21 [patent_title] => 'Methods and compositions for sealing tissue leaks' [patent_app_type] => new [patent_app_number] => 09/747293 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21901 [patent_no_of_claims] => 167 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20020022588.pdf [firstpage_image] =>[orig_patent_app_number] => 09747293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 517112 [patent_doc_number] => 07193039 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-20 [patent_title] => 'Synthesis of a potent parmagnetic agonist (epm-3) of the melanocyte stimulating hormone containing amino acid-type stable free radical' [patent_app_type] => utility [patent_app_number] => 10/168391 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3556 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/193/07193039.pdf [firstpage_image] =>[orig_patent_app_number] => 10168391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6875691 [patent_doc_number] => 20010000785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-05-03 [patent_title] => 'Multicomponent complex for use with a substrate' [patent_app_type] => new-utility [patent_app_number] => 09/740142 [patent_app_country] => US [patent_app_date] => 2000-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9346 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0000/20010000785.pdf [firstpage_image] =>[orig_patent_app_number] => 09740142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6736011 [patent_doc_number] => 20030013646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Methods to stimulate insulin production by pancreatic beta-cells' [patent_app_type] => new [patent_app_number] => 09/733634 [patent_app_country] => US [patent_app_date] => 2000-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 14671 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013646.pdf [firstpage_image] =>[orig_patent_app_number] => 09733634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1148061 [patent_doc_number] => 06774210 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-10 [patent_title] => 'Frozen food product' [patent_app_type] => B1 [patent_app_number] => 09/582296 [patent_app_country] => US [patent_app_date] => 2000-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3870 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/774/06774210.pdf [firstpage_image] =>[orig_patent_app_number] => 09582296 [rel_patent_id] =>[rel_patent_doc_number] =>)